These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21945937)

  • 41. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
    Kaplan FS; Xu M; Seemann P; Connor JM; Glaser DL; Carroll L; Delai P; Fastnacht-Urban E; Forman SJ; Gillessen-Kaesbach G; Hoover-Fong J; Köster B; Pauli RM; Reardon W; Zaidi SA; Zasloff M; Morhart R; Mundlos S; Groppe J; Shore EM
    Hum Mutat; 2009 Mar; 30(3):379-90. PubMed ID: 19085907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY.
    Beier EE; Sheu TJ; Dang D; Holz JD; Ubayawardena R; Babij P; Puzas JE
    J Biol Chem; 2015 Jul; 290(29):18216-18226. PubMed ID: 25975268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Msx2 exerts bone anabolism via canonical Wnt signaling.
    Cheng SL; Shao JS; Cai J; Sierra OL; Towler DA
    J Biol Chem; 2008 Jul; 283(29):20505-22. PubMed ID: 18487199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activin A amplifies dysregulated BMP signaling and induces chondro-osseous differentiation of primary connective tissue progenitor cells in patients with fibrodysplasia ossificans progressiva (FOP).
    Wang H; Shore EM; Pignolo RJ; Kaplan FS
    Bone; 2018 Apr; 109():218-224. PubMed ID: 29170109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Augmented BMP signaling commits cranial neural crest cells to a chondrogenic fate by suppressing autophagic β-catenin degradation.
    Yang J; Kitami M; Pan H; Nakamura MT; Zhang H; Liu F; Zhu L; Komatsu Y; Mishina Y
    Sci Signal; 2021 Jan; 14(665):. PubMed ID: 33436499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fructus Ligustri Lucidi preserves bone quality through induction of canonical Wnt/β-catenin signaling pathway in ovariectomized rats.
    Liu H; Guo Y; Zhu R; Wang L; Chen B; Tian Y; Li R; Ma R; Jia Q; Zhang H; Xia B; Li Y; Wang X; Zhu X; Zhang R; Brӧmme D; Gao S; Zhang D; Pei X
    Phytother Res; 2021 Jan; 35(1):424-441. PubMed ID: 32755017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways.
    Krause C; Korchynskyi O; de Rooij K; Weidauer SE; de Gorter DJ; van Bezooijen RL; Hatsell S; Economides AN; Mueller TD; Löwik CW; ten Dijke P
    J Biol Chem; 2010 Dec; 285(53):41614-26. PubMed ID: 20952383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postnatal Skeletal Deletion of Dickkopf-1 Increases Bone Formation and Bone Volume in Male and Female Mice, Despite Increased Sclerostin Expression.
    Colditz J; Thiele S; Baschant U; Niehrs C; Bonewald LF; Hofbauer LC; Rauner M
    J Bone Miner Res; 2018 Sep; 33(9):1698-1707. PubMed ID: 29734465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activin A receptor type 1-mediated BMP signaling regulates RANKL-induced osteoclastogenesis via canonical SMAD-signaling pathway.
    Omi M; Kaartinen V; Mishina Y
    J Biol Chem; 2019 Nov; 294(47):17818-17836. PubMed ID: 31619522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation.
    Guo J; Liu M; Yang D; Bouxsein ML; Saito H; Galvin RJ; Kuhstoss SA; Thomas CC; Schipani E; Baron R; Bringhurst FR; Kronenberg HM
    Cell Metab; 2010 Feb; 11(2):161-71. PubMed ID: 20142103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva.
    Chakkalakal SA; Zhang D; Culbert AL; Convente MR; Caron RJ; Wright AC; Maidment AD; Kaplan FS; Shore EM
    J Bone Miner Res; 2012 Aug; 27(8):1746-56. PubMed ID: 22508565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dkk1 KO Mice Treated with Sclerostin Antibody Have Additional Increases in Bone Volume.
    Morse A; Cheng TL; Schindeler A; McDonald MM; Mohanty ST; Kneissel M; Kramer I; Little DG
    Calcif Tissue Int; 2018 Sep; 103(3):298-310. PubMed ID: 29845410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limb specific Acvr1-knockout during embryogenesis in mice exhibits great toe malformation as seen in Fibrodysplasia Ossificans Progressiva (FOP).
    Hildebrand L; Schmidt-von Kegler M; Walther M; Seemann P; Stange K
    Dev Dyn; 2019 May; 248(5):396-403. PubMed ID: 30854720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.
    Shi C; Iura A; Terajima M; Liu F; Lyons K; Pan H; Zhang H; Yamauchi M; Mishina Y; Sun H
    Sci Rep; 2016 Apr; 6():24256. PubMed ID: 27048979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenotype.
    Salazar VS; Zarkadis N; Huang L; Norris J; Grimston SK; Mbalaviele G; Civitelli R
    J Cell Sci; 2013 Nov; 126(Pt 21):4974-84. PubMed ID: 24006258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva.
    Hino K; Zhao C; Horigome K; Nishio M; Okanishi Y; Nagata S; Komura S; Yamada Y; Toguchida J; Ohta A; Ikeya M
    Stem Cell Reports; 2018 Nov; 11(5):1106-1119. PubMed ID: 30392977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus.
    Hildebrandt N; Colditz J; Dutra C; Goes P; Salbach-Hirsch J; Thiele S; Hofbauer LC; Rauner M
    Sci Rep; 2021 Jan; 11(1):1920. PubMed ID: 33479403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activin-dependent signaling in fibro/adipogenic progenitors causes fibrodysplasia ossificans progressiva.
    Lees-Shepard JB; Yamamoto M; Biswas AA; Stoessel SJ; Nicholas SE; Cogswell CA; Devarakonda PM; Schneider MJ; Cummins SM; Legendre NP; Yamamoto S; Kaartinen V; Hunter JW; Goldhamer DJ
    Nat Commun; 2018 Feb; 9(1):471. PubMed ID: 29396429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.
    van Dinther M; Zhang J; Weidauer SE; Boschert V; Muth EM; Knappik A; de Gorter DJ; van Kasteren PB; Frisch C; Mueller TD; ten Dijke P
    PLoS One; 2013; 8(4):e62295. PubMed ID: 23638027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.